Financials

Discussions Technicals Seasonals

GBIM fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

GlobeImmune, Inc. is a biopharmaceutical company. It engages in the development of therapeutic products for cancer and infectious diseases based on its proprietary Tarmogen platform. The company was founded by Donald Bellgrau, Richard C. Duke, and Alex Franzusoff on February 10, 1995 and is headquartered in Louisville, CO.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

GBIM does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company